Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-023610

Director sold 1,270 shares at $22.41 ($28,458)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Heyman Richard A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-09-16 Sale : show line 1 in the form 10b5-1 −1,270 $22.41 $28,458 129,103 D
Open-market sales · 1,270 sh · avg $22.41 · $28,458
Loading xslF345X05/form4-09182024_080929.xml…